Dr. Choudhury is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5841 S Maryland Ave
Department Of Internal Medicine, M/C 7082
Chicago, IL 60637Phone+1 773-795-0232Fax+1 773-702-2230
Education & Training
University of ChicagoResidency, Internal Medicine, 2016 - 2019
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 2015
Certifications & Licensure
FL State Medical License 2022 - Present
IL State Medical License 2024 - 2026
NJ State Medical License 2022 - 2025
NY State Medical License 2019 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- A Phase I First-in-Human Study of ABBV-011, a Seizure-Related Homolog Protein 6-Targeting Antibody-Drug Conjugate, in Patients with Small Cell Lung Cancer.Daniel Morgensztern, Neal Ready, Melissa L Johnson, Afshin Dowlati, Noura Choudhury
Clinical Cancer Research. 2024-11-15 - 1 citationsA Phase I/II Study of Valemetostat (DS-3201b), an EZH1/2 Inhibitor, in Combination with Irinotecan in Patients with Recurrent Small-Cell Lung Cancer.Noura J Choudhury, W Victoria Lai, Alex Makhnin, Glenn Heller, Juliana Eng
Clinical Cancer Research. 2024-09-03 - Chromothripsis-mediated small cell lung carcinoma.Natasha Rekhtman, Sam E Tischfield, Christopher A Febres-Aldana, Jake June-Koo Lee, Jason C Chang
Cancer Discovery. 2024-08-26
Press Mentions
ORYZON Reports Financial Results and Corporate Update for Quarter Ended September 30, 2024October 24th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
